These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2185694)

  • 1. [Clinical trial of KRN 8601 in patients with neutropenia induced by chemotherapy for lung cancer].
    Kimura I; Ohonoshi T; Okabe T; Takaku F; Nishiwaki H; Saijo N; Ikegami H; Fukuoka M; Furuse K
    Gan To Kagaku Ryoho; 1990 May; 17(5):999-1003. PubMed ID: 2185694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma--a multi-institutional placebo controlled double-blind comparative study].
    Ogawa M; Masaoka T; Mizoguchi H; Takaku F; Nakashima M
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):365-73. PubMed ID: 1689988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for lung cancer. rG.CSF Cooperation Study Group].
    Ota K; Ariyoshi Y; Fukuoka M; Furuse K; Niitani H
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):65-71. PubMed ID: 1688700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outline of clinical studies on recombinant human granulocyte colony stimulating factor (KRN 8601) in Japan.
    Kaneko T; Takaku F; Ogawa M
    Tokai J Exp Clin Med; 1991 Mar; 16(1):51-61. PubMed ID: 1723550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.
    Eguchi K; Sasaki S; Tamura T; Sasaki Y; Shinkai T; Yamada K; Soejima Y; Fukuda M; Fujihara Y; Kunitou H
    Cancer Res; 1989 Sep; 49(18):5221-4. PubMed ID: 2475245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
    Crawford J; George M
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Shi YK; Sun Y; Su M
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized controlled study of leucomax (recombinant human granulocyte-macrophage colony stimulating factor, rhGM-CSF) in the treatment of cancer chemotherapy-induced leucopenia].
    Feng F; Zhou L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):451-3. PubMed ID: 10920943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H; Bando H; Takishita Y
    Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
    Yamamoto N; Sekine I; Nakagawa K; Takada M; Fukuoka M; Tanigawara Y; Saijo N
    Jpn J Clin Oncol; 2009 Jul; 39(7):425-30. PubMed ID: 19395467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J
    N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
    Haematol Blood Transfus; 1990; 33():717-23. PubMed ID: 2182461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of fever to infection in patients with chemotherapy-induced neutropenia].
    Ruan YP; Zhang WY
    Ai Zheng; 2008 Aug; 27(8):879-81. PubMed ID: 18710626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.